The Krebs cycle, also known as the citric acid cycle or the tricarboxylic acid (TCA) cycle, is a central metabolic pathway that links carbohydrate, fat, and protein oxidation to the production of energy-rich electron carriers. These carriers are essential because they transport high-energy electrons to the electron transport chain, where the majority of cellular ATP is generated. Understanding which electron carriers function in the Krebs cycle provides insight into how cells convert fuel into usable energy and highlights the cycle's important role in bioenergetics The details matter here..
At the heart of the Krebs cycle are a series of redox reactions. In each turn of the cycle, acetyl-CoA is oxidized, releasing carbon dioxide and generating molecules that carry electrons. So the primary electron carriers directly produced during these reactions are nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH₂). Plus, while both donate electrons to the electron transport chain, they differ in their chemical structure, the number of electrons they carry, and the protein complexes they ultimately feed into. A third carrier, nicotinamide adenine phosphate (NADPH), is more commonly associated with anabolic pathways, but its related nucleotide plays specialized roles in certain cellular compartments. Nonetheless, NADH and FADH₂ remain the principal electron carriers arising from the Krebs cycle.
The cycle begins in the mitochondrial matrix, where acetyl-CoA combines with oxaloacetate to form citrate. Worth adding: through a sequence of eight enzymatic steps, citrate is reconverted to oxaloacetate, completing the cycle. During this process, three NAD⁺ molecules are reduced to NADH at the isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, and malate dehydrogenase steps. Day to day, each of these reactions involves the transfer of a hydride ion (H⁻) from the substrate to NAD⁺, resulting in NADH that is free to diffuse toward the inner mitochondrial membrane. The reduction of NAD⁺ is energetically favorable and represents the most frequent electron donor activity within the cycle.
In addition to NADH, one FADH₂ molecule is produced per turn of the Krebs cycle. So this occurs during the succinate dehydrogenase reaction, where succinate is oxidized to fumarate. Because of that, unlike NAD⁺, which is a water-soluble cofactor freely diffusing in the matrix, FAD is tightly bound to the succinate dehydrogenase enzyme, which is embedded in the inner mitochondrial membrane. 5 ATP per molecule, while FADH₂ yields about 1.This difference in entry point directly impacts the amount of ATP ultimately produced: NADH yields approximately 2.Still, because of this association, the electrons donated by FADH₂ enter the electron transport chain at a later stage—specifically at ubiquinone (coenzyme Q)—compared to NADH, which feeds into complex I. 5 ATP, reflecting their distinct roles and positions in the chain That's the part that actually makes a difference..
Beyond NADH and FADH₂, the Krebs cycle also involves transient interactions with other redox-active molecules. On the flip side, for instance, coenzyme A carries the acetyl group into the cycle but does not itself serve as an electron carrier; it is regenerated after each turn. Additionally, the cycle produces GTP (or ATP in some organisms) via substrate-level phosphorylation at the succinyl-CoA synthetase step, which is energetically distinct from electron carrier generation. Some organisms and specialized cells may apply NADP⁺ instead of NAD⁺ under certain conditions, producing NADPH that can be diverted into biosynthetic pathways, though this is not the canonical function of the cycle in most aerobic tissues It's one of those things that adds up. Turns out it matters..
The electron carriers generated in the Krebs cycle do not remain within the cycle itself; they are immediately exported to the inner mitochondrial membrane to participate in oxidative phosphorylation. NADH transfers its electrons to complex I (NADH dehydrogenase), initiating a series of proton-pumping events that create an electrochemical gradient. FADH₂, entering at complex II (succinate dehydrogenase), does not pump protons but still passes
